Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
HDFC Mutual Fund · Equity · Sectoral/ Thematic
₹21.25
AUM: —
NAV updated about 2 months ago
Plan
Direct
Option
Growth
Risk
Very High
Expense Ratio
—
Exit Load
—
Fund Manager
—
Inception
—
Benchmark
—
Sharpe Ratio
0.61
Std Dev (1Y)
13.67%
Historical Returns (CAGR)
Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.
1m
+2.82%
3m
+13.31%
6m
+14.87%
1y
+20.84%
3y
—
5y
—
10y
—
since inception
+30.34%
rate_review TopFund's Take on HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is a Sectoral/ Thematic fund from HDFC Mutual Fund.
Cost: Expense ratio data for this fund isn't available yet.
Risk-adjusted performance: Over the trailing 1-year period, the fund shows a moderate Sharpe ratio of 0.61 — decent risk-adjusted performance, without being exceptional. Separately, annualised volatility of 13.67% is fairly typical for actively managed equity funds.
Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.
This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.
donut_small Sector Allocation
Sector allocation not available yet.
pie_chart Asset Allocation
Asset allocation not available yet.
info Fund Snapshot
Similar Funds
Invesco India Financial Services Fund - Direct Plan - Growth
Invesco Mutual Fund
Franklin India Opportunities Fund - Direct - Growth
Franklin Templeton Mutual Fund
ICICI Prudential Manufacturing Fund - Direct Plan - Cumulative Option
ICICI Prudential Mutual Fund
TATA India Consumer Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option
Tata Mutual Fund
DSP India T.I.G.E.R. Fund - Direct Plan - Growth
DSP Mutual Fund
Invesco India PSU Equity Fund - Direct Plan - Growth
Invesco Mutual Fund
tips_and_updates Tools & Guides for This Fund
Frequently Asked Questions about HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
The current NAV (Net Asset Value) of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is ₹21.25. NAV is updated every business day after market close by AMFI.
1Y: 20.84%
Expense ratio data is not yet available.
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is managed by HDFC Mutual Fund.
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is a Very High risk fund. Suitable for aggressive investors with a 5+ year horizon.
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is a Sectoral/ Thematic fund. SIP suitability depends on your investment goal and risk profile.
AUM data is not yet available.
* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.